Healthcare provider profile · identity verified

Timothy James Muhonen, MD

Family Practice · MOUNTAIN HOME, ID · NPI 1780752469

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	872	244
Levothyroxine Sodium	Levothyroxine Sodium	502	124
Losartan Potassium	Losartan Potassium	400	118
Amlodipine Besylate	Amlodipine Besylate	362	102
Lisinopril	Lisinopril	349	102
Metoprolol Succinate	Metoprolol Succinate	285	87
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	284	38
Furosemide	Furosemide	227	74
Citalopram Hbr	Citalopram Hydrobromide	219	58
Omeprazole	Omeprazole	216	76
Famotidine	Famotidine	199	60
Potassium Chloride	Potassium Chloride	199	60
Metformin Hcl	Metformin Hcl	194	59
Rosuvastatin Calcium	Rosuvastatin Calcium	193	63
Albuterol Sulfate Hfa	Albuterol Sulfate	189	67
Tamsulosin Hcl	Tamsulosin Hcl	189	58
Trazodone Hcl	Trazodone Hcl	173	40
Gabapentin	Gabapentin	169	49
Sertraline Hcl	Sertraline Hcl	153	36
Pravastatin Sodium	Pravastatin Sodium	152	32
Duloxetine Hcl	Duloxetine Hcl	136	26
Eliquis	Apixaban	135	36
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	134	18
Jardiance	Empagliflozin	131	41
Buspirone Hcl	Buspirone Hcl	119	33
Allopurinol	Allopurinol	109	26
Hydrochlorothiazide	Hydrochlorothiazide	106	30
Metformin Hcl Er	Metformin Hcl	106	27
Carvedilol	Carvedilol	103	34
Fluticasone Propionate	Fluticasone Propionate	99	46
Glipizide	Glipizide	96	28
Metoprolol Tartrate	Metoprolol Tartrate	95	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	91	23
Mirtazapine	Mirtazapine	89	41
Clopidogrel	Clopidogrel Bisulfate	88	26
Prednisone	Prednisone	79	42
Warfarin Sodium	Warfarin Sodium	79	24
Pregabalin	Pregabalin	78	20
Alendronate Sodium	Alendronate Sodium	73	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	72	28
Atenolol	Atenolol	68	19
Lovastatin	Lovastatin	67	18
Ezetimibe	Ezetimibe	64	22
Tizanidine Hcl	Tizanidine Hcl	59	20
Meloxicam	Meloxicam	58	24
Tramadol Hcl	Tramadol Hcl	57	11
Oxycodone Hcl	Oxycodone Hcl	55	11
Alprazolam	Alprazolam	54	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	54	23
Ozempic	Semaglutide	52	11
Fluoxetine Hcl	Fluoxetine Hcl	51	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	51	14
Donepezil Hcl	Donepezil Hcl	49	12
Propranolol Hcl	Propranolol Hcl	48	11
Azithromycin	Azithromycin	46	29
Escitalopram Oxalate	Escitalopram Oxalate	44	14
Quetiapine Fumarate	Quetiapine Fumarate	44	11
Zolpidem Tartrate	Zolpidem Tartrate	44	suppressed
Lorazepam	Lorazepam	43	suppressed
Xarelto	Rivaroxaban	43	11
Nystatin	Nystatin	42	17
Spironolactone	Spironolactone	40	15
Finasteride	Finasteride	38	12
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Simvastatin	Simvastatin	37	suppressed
Acyclovir	Acyclovir	36	11
Baclofen	Baclofen	36	suppressed
Digoxin	Digoxin	36	suppressed
Montelukast Sodium	Montelukast Sodium	36	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Estradiol	Estradiol	34	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	suppressed
Ipratropium Bromide	Ipratropium Bromide	31	20
Bupropion Xl	Bupropion Hcl	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	12
Valacyclovir	Valacyclovir Hcl	30	suppressed
Azelastine Hcl	Azelastine Hcl	28	11
Memantine Hcl	Memantine Hcl	28	suppressed
Myrbetriq	Mirabegron	28	11
Synthroid	Levothyroxine Sodium	28	suppressed
Telmisartan	Telmisartan	28	suppressed
Amoxicillin	Amoxicillin	27	23
Nitroglycerin	Nitroglycerin	27	18
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Cephalexin	Cephalexin	23	21
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Lamotrigine	Lamotrigine	23	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	23	suppressed
Torsemide	Torsemide	23	suppressed
Diazepam	Diazepam	22	suppressed
Ondansetron Odt	Ondansetron	22	16
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	17
Breyna	Budesonide/Formoterol Fumarate	21	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Risperidone	Risperidone	21	suppressed
Valsartan	Valsartan	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Topiramate	Topiramate	19	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	18	suppressed
Fluconazole	Fluconazole	18	13
Methimazole	Methimazole	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Letrozole	Letrozole	17	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Metronidazole	Metronidazole	16	15
Nifedipine Er	Nifedipine	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Constulose	Lactulose	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Flecainide Acetate	Flecainide Acetate	14	suppressed
Lactulose	Lactulose	14	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	11
Felodipine Er	Felodipine	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Galantamine Hbr	Galantamine Hbr	12	suppressed
Naproxen	Naproxen	12	suppressed
Temazepam	Temazepam	12	suppressed
Acarbose	Acarbose	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Primidone	Primidone	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error